Self-care and communication issues at the end of life of recipients of a left-ventricular assist device as destination therapy

Current Opinion in Supportive and Palliative Care

Volumn 7, Issue 1, 2013, Pages 29-35

  Gal, Tuvia Ben ^a   Jaarsma, Tiny ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Communication; End of life; Palliative care; Team; Ventricular assist device

Indexed keywords

AGED; CAREGIVER; CASE REPORT; COMORBIDITY; DISEASE COURSE; EDUCATION; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; HUMAN RELATION; INTERPERSONAL COMMUNICATION; LIVING WILL; MALE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PALLIATIVE THERAPY; PATIENT CARE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SELF CARE; STANDARD; TERMINALLY ILL PATIENT;

ADVANCE DIRECTIVES; AGED; CAREGIVERS; COMMUNICATION; COMORBIDITY; DISEASE PROGRESSION; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; PALLIATIVE CARE; PATIENT CARE TEAM; PROFESSIONAL-FAMILY RELATIONS; PROFESSIONAL-PATIENT RELATIONS; QUALITY OF LIFE; SELF CARE; TERMINALLY ILL;

EID: 84877938461     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32835d2d50     Document Type: Review

References (37)

1. McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-1847. Comprehensive multidisciplinary guidelines addressing care of heart failure patients, indications for VAD and palliative care issues.
2. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the Post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505.
3. Kirklin JK, Naftel DC Pagani FD, et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 2012;144:584-603.
4. Rogers JG, Aaronson KD, Boyle AJ, et al., HeartMate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010;55:1826-1834.
5. Yuan N, Arnaoutakis GJ, George TJ, et al. The spectrum of complications following left ventricular assist device placement. J Card Surg 2012;27:630-638.
6. Swetz KM, Ottenberg AL, Freeman MR, Mueller PS. Palliative care and endof- life issues in patients treated with left ventricular assist devices as destination therapy. Curr Heart Fail Rep 2011;8:212-218. This review summarizes the QOL, psychosocial, care giving, and ethical issues in caring for patients with left ventricular assist devices as destination therapy. The review offers practical suggestions on addressing them, and comments on the practical aspects of end-of-life management of these patients.
7. Brouwers C, Denollet J, de Jonge N, et al. Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice. Circ Heart Fail 2011;4:714-723.
8. Byram EK. Upstream palliative care for the patient with a left ventricular assist device as destination therapy. Dimensions Crit Care Nurs 2012;31:18-24. This article presents the need for a broader approach in caring for patients with a LVAD, with practical description of a palliative care approach and interventions.
9. Swetz K, Freeman M, AbouEzzeddine OF, et al. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc 2011;86:493-500.
10. Slaughter MS, Rogers JG, Milano CA et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-2251.
11. Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011;57:1890-1898.
12. Wieselthaler GM, O Driscoll G, Jansz P, et al.;HVAD Clinical Investigators. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multiinstitutional trial. J Heart Lung Transplant 2010;29:1218-1225.
13. Copeland JG, Copeland H, Gustafson M, et al. Experience with more than 100 total artificial heart implants. J Thorac Cardiovasc Surg 2012;143:727-734.
14. Riegel B, Jaarsma T, Strömberg A. A Middle-range theory of self-care of chronic illness. Advances Nurs Sci 2012;35:194-204.
15. Casida JM, Peters RM, Magnan MA. Self-care demands of persons living with an implantable left-ventricular assist device. Res Theory Nurs Pract 2009;23:279-293.
16. Slaughter MS, Pagani FD, Rogers JG, et al., HeartMate II Clinical Investigators. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010;29:S1-S39.
17. Ben Gal T, Jaarsma T. Patients with a left ventricular assist device: the new chronic patient in cardiology. Eur J Cardiovasc Nurs 2012. [Epub ahead of print]. doi: 10.1177/1474515112441145.
18. Overgaard D, Grufstedt Kjeldgaard H, Egerod I. Life in transition: a qualitative study of the illness experience and vocational adjustment of patients with left ventricular assist device. J Cardiovasc Nurs 2012;27:394-402.
19. Low J, Pattenden J, Candy B, et al. Palliative care in advanced heart failure: an international review of the perspectives of recipients and health professionals on care provision. J Card Fail 2011;17:231-252.
20. Slaughter MS, Meyer AL Birks EJ. Destination therapy with left ventricular assist devices: patient selection and outcomes. Curr Opin Cardiol 2011;26:232-236.
21. Heilmann C, Kuijpers N, Beyersdorf F, et al. Supportive psychotherapy for patients with heart transplantation or ventricular assist devices. Eur J Cardiothorac Surg 2011;39:e44-e50.
22. Egerod I, Overgaard D. Taking a back seat: support and self-preservation in close relatives of patients with left ventricular assist device. Eur J Cardiovasc Nurs 2012 [Epub ahead of print]. doi: 10.1177/1474515111435609. This qualitative study used data from a paired interview and one group interview with LVAD patients' close relatives.
23. Baker K, Flattery M, Salyer J, et al. Caregiving for patients requiring left ventricular assistance device support. Heart Lung 2010;39:196-200.
24. Heyland DK, Dodek P, Rocker G, et al., Canadian Researchers End-of-Life Network (CARENET). What matters most in end-of-life care: perceptions of seriously ill patients and their family members? CMAJ 2006;174:627-633.
25. Barclay S, Momen N, Case-Upton S, et al. End-of-life care conversations with heart failure patients: a systematic literature review and narrative synthesis. Br J Gen Pract 2011;61:e49-e62. This review included studies of heart failure patients and/or there healthcare professions concerning discussion of end of live care. A narrative synthesis of emergent themes was included.
26. Barnes S, Gott M, Payne S, et al. Communication in heart failure: perspectives from older people and primary care professionals. Health Soc Care Commun 2006;14:482-490.
27. Brush S, Budge D, Alharethi R, et al. End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant 2010;29:1337-1341.
28. MacIver J, Ross H. Withdrawal of ventricular assist device support. J Palliat Care 2005;21:151-156.
29. Mueller P, Swetz K, Freeman M, et al. Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc 2010;85:791-797.
30. Rady MY, Verheijde JL. Ethical challenges with deactivation of durable mechanical circulatory support at the end of life: left ventricular assist devices and total artificial hearts. J Intensive Care Med 2012 [Epub ahead of print]. doi: 10.1177/0885066611432415.
31. Clark AM, Jaarsma T, Strachan P, et al. Effective communication and ethical consent in decisions related to ICDs. Nat Rev Cardio 2011;8:694-705.
32. Rizzieri AG, Verheijde JL, Rady MY, McGregor JL. Ethical challenges with the left ventricular assist device as a destination therapy. Philos Ethics Humanit Med 2008;3:20.
33. Murray MA Osaki S, Edwards NM, et al. Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy. Interact Cardiovasc Thorac Surg 2009;8:84-88.
34. Princer K. The role of a clinical engineer within a mechanical circulatory support device program: a single center's experience. Prog Transplant 2010;20:148-154.
35. Von Ruden SA, Murray MA Grice JL, et al. The pharmacotherapy implications of ventricular assist device in the patient with end-stage heart failure. J Pharm Pract 2012;25:232-249.
36. Wilson SR, Givertz MM, Stewart GC, Mudge GH Jr. Ventricular assist devices the challenges of outpatient management. J Am Coll Cardiol 2009;54:1647-1659.
37. Schwarz ER, Philip KJ, Simsir SA, et al. Maximal care considerations when treating patients with end-stage heart failure: ethical and procedural quandaries in management of the very sick. Journal of Religion and Health 2011;50:872-879. This article reflects on the multitude of critical issues that healthcare providers have to face while caring for patients with end-stage heart failure.